Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea



Rating:

Share or cite this content

Citations should be made in the following way:
A. Pack (Philadelphia, United States Of America). The role of pharmacological treatments in sleep apnoea syndrome. Annual Congress 2004 - What's new in the treatment of sleep apnoea

Member's Comments

No comment yet.

Related content which might interest you: Are psychological therapies useful in the treatment of sleep apnoea syndrome? Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea Year: 2004 The importance of sleep position in treatment planning of patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Treatment options for sleep apnoea in children with Down syndrome Source: Annual Congress 2012 - Treatment of paediatric sleep-disordered breathing in special populations Year: 2012 Possible role of sleep apnoea treatment in dementia Source: Sleep and Breathing Conference 2021 Year: 2021 The frequency of overlap syndrome in patients who were evaluated in sleep laboratory and its effects on severity of obstructive sleep apnea syndrome and quality of sleep Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 The role of inflammatory biomarkers in obstructive sleep apnea syndrome Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018 Could obstructive sleep apnea syndrome be a component of metabolic syndrome? Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 Pathophysiological consequences of obstructive sleep apnoea Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases Year: 2006 Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 The puzzle of metabolic effects of obstructive sleep apnoea in children Source: Eur Respir J 2016; 47: 1050-1053 Year: 2016 Night treatment with long acting ß2 agonists in mild COPD patients with sleep apnoea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 74s Year: 2007 Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy? Source: Eur Respir J 2013; 41: 368-375 Year: 2013 Sleep apnoea and hypoventilation syndromes: management and therapies Source: International Congress 2017 – PG13 Sleep-disordered breathing: diagnosis and therapy Year: 2017 Sleep apnoea and hypoventilation syndromes: management and therapies Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Sleep apnoea and hypoventilation syndromes: management and therapies Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Sleep apnoea and hypoventilation syndromes: management and therapies Source: ERS Skills Course 2016 Year: 2016 Sleep apnoea and hypoventilation syndromes: management and therapies Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017